Gerresheimer has been positioned strongly in India for many years through Kundli’s Triveni Polymers Pvt Ltd.
A second production site is now being opened in the city of Kosamba to help bolster production capacity to cope with the high demand for Triveni round containers. The official opening ceremony will take place on December 16 on the site’s premises in Kosamba, in the district of Surat, with international guests invited to attend.
“Today marks the start of a new chapter in the success story of Gerresheimer and Triveni. We acquired a majority stake in the company on 18 December 2012 and now, seven years later, we are opening a new production site to boost our capacity”: this is what Niels Düring, Global Executive Vice President at Gerresheimer Plastic Packaging, will be saying at the official opening of the new plant in Kosamba on 16 December 2019.
He will add that, with the second site up and running and the warehouses available in Hyderabad, it will be possible to significantly reduce the time it takes to deliver products to customers, enhance supply performance, cover a wider area, and ensure business continuity.
His welcoming speech will follow a presentation of the plant by Jari Tevajarvi, Vice President Asia Plastic Packaging, and Plant Manager Prakash Dhameja. The ceremony is set to attract numerous guests from both India and abroad, including official representatives from the local region.
Production of Triveni round containers is due to begin in class-8 and class-9 clean rooms at the end of the year. At the same plant, Gerresheimer Pharmaceutical Packaging Mumbai Pvt. Ltd. will be making vials out of tubular glass for pharmaceutical and diagnostic applications, as well as ampoules. Next in the pipeline is a new production facility that is being built as a greenfield project on the same industrial park.
Gerresheimer is a leading global partner to the pharma and healthcare industry. With speciality glass and plastic products, the Company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers.
With our plants in Europe, North America, South America, and Asia, we generate revenues of approximately EUR 1.4 billion. Our comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, micro pumps, prefillable syringes, injection vials, ampoules, bottles, and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.
For more information, please fill out the enquiry form attached to this page.